NCT05736471 Cognitive and Affective Processes Online
| NCT ID | NCT05736471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2023-02-15 |
| Primary Completion | 2027-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2023-02-15 with a primary completion date of 2027-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will provide data for evaluating the psychometric characteristics of the tests assessing cognitive flexibility, including their (1) internal consistency, (2) feasibility and tolerability, their (3) convergent and discriminant validity of cognitive and affective constructs such as those introduced to understand mental disorders, and (4) sensitivity (and correspondence) to individual differences. For these tests to be useful in studying clinical conditions, they must show adequate reliability, validity, and sensitivity in large samples of convenience.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years or older * English-speaking * Live in the U.S. * Have access to an internet connected computer * Users of the mTurk and Prolific survey website Exclusion Criteria: * NA
Contact & Investigator
Alexander Herman
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT05736471 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05736471 currently recruiting?
Yes, NCT05736471 is actively recruiting participants. Contact the research team at maple036@umn.edu for enrollment information.
Where is the NCT05736471 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT05736471 clinical trial?
NCT05736471 is sponsored by University of Minnesota. The principal investigator is Alexander Herman at University of Minnesota. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.